首页> 外国专利> Antibody antibody, antibody or derivative, antibody derivative, combination of an antibody or derivative, pharmaceutical composition, method, polypeptide, nucleic acid encoding an antibody or derivative thereof, vector, expression system, non-human transgenic mammal and kit I understand an antibody or derivative

Antibody antibody, antibody or derivative, antibody derivative, combination of an antibody or derivative, pharmaceutical composition, method, polypeptide, nucleic acid encoding an antibody or derivative thereof, vector, expression system, non-human transgenic mammal and kit I understand an antibody or derivative

机译:抗体,抗体或衍生物,抗体衍生物,抗体或衍生物的组合,药物组合物,方法,多肽,编码抗体或其衍生物的核酸,载体,表达系统,非人转基因哺乳动物和试剂盒衍生物

摘要

An anti-TrkA antibody is provided that comprises: a) a variable heavy chain comprising a sequence selected from any of BXhVH1, BXhVH2, BXhVH3, BXhVH4, BXhVH5, or HuVHWOv as shown in FIG. 1a; or from variants of any of said sequences and/or b) a variable light chain comprising a sequence selected from any of BXhVL1, BXhVL2, BXhVL3, BXhVL4, BXhVL5, BXhVL6, BXhVL7 or BXhVL8; as shown in FIG. 1b, or from variants of any of said sequences. TrkA-binding derivatives are also provided. Antibodies or derivatives of the present invention are useful in a number of therapies, including pain therapy.
机译:提供了一种抗-TrkA抗体,其包含:a)可变重链,其包含选自BXhVH1,BXhVH2,BXhVH3,BXhVH4,BXhVH5或HuVHWOv中的任一个的序列。 1a;或来自任何所述序列的变体和/或b)包含选自以下的序列的可变轻链:BXhVL1,BXhVL2,BXhVL3,BXhVL4,BXhVL5,BXhVL6,BXhVL7或BXhVL8。如图1b,或来自任何所述序列的变体。还提供了TrkA结合衍生物。本发明的抗体或衍生物可用于许多疗法,包括疼痛疗法。

著录项

  • 公开/公告号BRPI0905955A2

    专利类型

  • 公开/公告日2015-08-04

    原文格式PDF

  • 申请/专利权人 LAY LINE GENOMICS S.P.A.;

    申请/专利号BR2009PI05955

  • 发明设计人 FABIO BENIGNI;DANIELE D AMBROSIO;

    申请日2009-02-04

  • 分类号C10L5/44;

  • 国家 BR

  • 入库时间 2022-08-21 15:16:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号